Objective
To generate income and achieve capital growth, whilst seeking to maintain lower levels of portfolio volatility than traditional equity portfolios by adopting a multi-asset strategy.
Management group
J.P. Morgan Asset Management
Launch date
02/03/2018
Domicile
United Kingdom
Fund manager
Katy Thorneycroft, Gareth Witcomb
Dividend frequency
Quarterly
Wind-up provisions
In accordance with the Articles, the Directors are required to propose an ordinary resolution that the Company continues its business as a closed-ended investment company at the fifth AGM of the Company expected to be held in 2023. If the Continuation Vote is passed by a simple majority, the Directors are required to put a further Continuation Vote to Shareholders at the AGM of the Company every fifth year thereafter.
Total assets (m) Market Cap (m) Price (last close) NAV Dividend dates Discount / premium (%) Gearing (%) Dividend yield (%) AIC ongoing charge (%)
86.29 84.08 104.75 107.50 Mar, Jun, Sep, Dec -2.56 0 3.91 1.04 (28/02/2021)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Dividend type Special dividend Financial year
23/12/2021 04/02/2022 1.025 Income No 2022
30/09/2021 05/11/2021 1.025 Income No 2022
01/07/2021 06/08/2021 1.025 Income No 2022
01/04/2021 06/05/2021 1.000 Income No 2021
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
JPMorgan Multi-Asset Growth & Income Share price total return 21.1 28.0 N/A N/A
Flexible Investment AIC sector Share price total return 19.4 21.4 31.2 122.0
Scroll

Share structure

Number of shares
80,268,408

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 35,692 3,333,888 28,007,228 0
Average N/A 33,151 128,733 0
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.04 2.98 24.19 0
Average N/A 0.04 0.13 0
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BFWJJT14 MATE GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 31/12/2021

Investment % of total assets
Procter & Gamble 5.0
Johnson & Johnson 4.7
Coca-Cola 4.5
Roche 3.8
AbbVie 3.4
Texas Instruments 2.7
Nestle 2.6
McDonalds 2.5
Bristol-Myers Squibb 2.4
Novo Nordisk 2.3

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.